BioSpace News Archive

Business

Joseph A. Bosco III, MD, named first vice president of the American Academy of Orthopaedic Surgeons

Joseph A. Bosco III, MD, was named first vice president of the American Academy of Orthopaedic Surgeons at its 2019 Annual Meeting.

March 15, 2019
·
2 min read
Genetown

The Bioinformatics Infrastructure Congress launches in Boston on May 7-9, 2019

The Bioinformatics Infrastructure Congress is the first bioinformatics conference that is solely focussed on tools and unit set-up, rather than application.

March 15, 2019
·
2 min read
Pharm Country

Adlai Nortye’s Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC

Adlai Nortye Ltd., a global clinical-stage biopharmaceutical company released the animal model data of Buparlisib at the 7th ICHNO, the International Conference on Innovative Approaches in Head & Neck Oncology.

March 15, 2019
·
2 min read
Business

Wiley and The Norwegian Directorate for ICT and Joint Services in Higher Education and Research Partner to Advance Scholarly Research and Publishing in Norway

John Wiley & Sons, Inc., a global leader in research and education, and Unit - The Norwegian Directorate for ICT and Joint Services in Higher Education and Research - announced a combined open access and subscription agreement effective March 14, 2019.

March 15, 2019
·
2 min read
BioMidwest

Mallinckrodt’s Hobart, N.Y. and St. Louis, Mo. Sites Recognized as 2019 Manufacturing Leadership Award Winners

Hobart site honored for second year in a row, recognized this year for talent management leadership

March 15, 2019
·
6 min read
Drug Development

Sutro Biopharma Initiates Phase I Clinical Trial of STRO-002 for the Treatment of Ovarian and Endometrial Cancers

Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that it has dosed the first patient in a Phase I study of STRO-002, an anti-folate receptor alpha (FoIRα) antibody-drug conjugate (ADC), in patients with ovarian and endometrial cancers.

March 15, 2019
·
5 min read
Pharm Country

Valisure Expands Capabilities To Test Medications For Cancer Causing Contaminants Implicated In Recent Recalls

NDEA and NDMA impurities have been responsible for numerous recalls of hypertension medications and Valisure is now the first pharmacy to test for them in every batch

March 15, 2019
·
3 min read
Job Trends

Spectrum Pharmaceuticals Provides BLA Filing Update for ROLONTIS® (eflapegrastim)

Spectrum Pharmaceuticals, Inc. announced that due to the U.S. Food and Drug Administration’s request for additional manufacturing-related information for ROLONTIS, the company has voluntarily withdrawn its Biologics License Application.

March 15, 2019
·
4 min read
Business

Diplomat Appoints Daniel Davison as Chief Financial Officer

The company’s board of directors has appointed Dan Davison as chief financial officer and treasurer effective April 8, succeeding Atul Kavthekar.

March 15, 2019
·
4 min read
Deals

Constellation Alpha Capital Corp. Signs Letter of Intent to Acquire DermTech, Inc., a leading innovator of genomics for dermatology and non-invasive skin cancer diagnosis

Constellation Alpha Capital Corp., a special purpose acquisition company, announced that it has executed a non-binding Letter of Intent to merge with DermTech, Inc., a molecular genomics company, with an initial focus on skin cancer, that develops and markets novel non-invasive diagnostic tests.

March 15, 2019
·
7 min read